RECRUITING

COVID-19 Survivorship Registry

Talk to us

Conditions

Covid19

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.

Official Title

Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database

Quick Facts

Study Start:2020-07-17
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04527315

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * have tested positive for SARS-CoV-2 and discharged from the ICU or,
  2. * have tested positive for SARS-CoV-2 and have been discharged from hospital or,
  3. * have tested positive for SARS-CoV-2 but was NOT hospitalized
  4. * ages 18 and over, and
  5. * competent and willing to sign informed consent and comply to all aspects of the protocol
  6. * No clinical history of COVID-19,
  7. * No active clinical symptoms indicative of possible COVID-19,
  8. * Ages 18 and over,
  9. * competent and willing to sign informed consent and comply to all aspects of the protocol
  1. * Participants who are pregnant or currently trying to get pregnant
  2. * Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants)
  3. * Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning.
  4. * Pace maker
  5. * Poorly controlled diabetes
  6. * Poorly controlled Restrictive lung disease
  7. * Heart failure
  8. * Parkinson's Disease
  9. * Hypertension
  10. * Any diagnosis or history of autonomic neuropathy

Contacts and Locations

Study Contact

Sasha Basdeo
CONTACT
929-455-5968
sasha.basdeo@nyulangone.org
Shruthy Shankar
CONTACT
212-263-1212
shruthy.shankar@nyulangone.org

Principal Investigator

Rany Condos, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Rany Condos, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-07-17
Study Completion Date2027-12

Study Record Updates

Study Start Date2020-07-17
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Covid19